WO2005000190A1 - 眼灌流液収容体 - Google Patents
眼灌流液収容体 Download PDFInfo
- Publication number
- WO2005000190A1 WO2005000190A1 PCT/JP2004/009140 JP2004009140W WO2005000190A1 WO 2005000190 A1 WO2005000190 A1 WO 2005000190A1 JP 2004009140 W JP2004009140 W JP 2004009140W WO 2005000190 A1 WO2005000190 A1 WO 2005000190A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- packaging material
- soft bottle
- solution
- chamber
- container according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2093—Containers having several compartments for products to be mixed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2031—Separating means having openings brought into alignment
Definitions
- the present invention relates to an eye perfusion solution container.
- Oxygnoletathione is stable in the acidic region, but unstable in the neutral region.
- Bicarbonate is stable in the basic region. Therefore, in order to keep both components stable, the oxygnoretathione solution and the bicarbonate solution are stored separately in stable pH ranges, and are stored and used in a form of mixing both solutions at the time of use. Since bicarbonate solution releases carbon dioxide gas during storage, glass containers with gas barrier properties are used to prevent this.
- an eye perfusion solution has been sold in a two-bottle form in which an oxygnoretathione solution and a bicarbonate solution are respectively contained in glass containers (BSS Plus, Santen Pharmaceutical Co., Ltd.).
- Such a multi-chamber bag is said to be capable of mixing both solutions without using an infusion needle, making the mixing operation relatively easy and convenient for disposal.
- Patent Document 1 Patent No. 3116118
- Patent Document 2 JP-A-2000-281147
- Patent Document 3 Japanese Patent Application Laid-Open No. 2000-288066 Disclosure of the invention
- An object of the present invention is to provide an eye perfusion solution container which solves the above-mentioned problems, has high convenience at the time of disposal, is easy to store, and has excellent workability in mixing two solutions when used. is there.
- a first characteristic configuration of the eye perfusion solution container of the present invention is that an oxydaltathione-containing solution and a bicarbonate solution are filled into a self-supporting, time-of-use mixing integrated plastic soft bottle. It is in.
- a second characteristic configuration of the eye perfusion liquid container of the present invention is the above-mentioned characteristic configuration
- a oxygnoretathion-containing solution is sealed in the first chamber
- a bicarbonate solution is sealed in the second chamber.
- a mixing mechanism that allows the first chamber and the second chamber to communicate with each other during use so that the oxidadarthion-containing solution and the bicarbonate solution can be mixed.
- a packaging material made of gas-impermeable plastic for packaging the soft bottle is provided.
- a fourth characteristic configuration of the eye perfusion solution container of the present invention is the above-mentioned characteristic configuration, wherein the packaging material is preferably a free-standing bottomed type.
- a space between the soft bottle and the packaging material is filled with air or nitrogen gas.
- an oxygen detector is sealed in a space between the soft bottle and the packaging material.
- an oxygen scavenger is further sealed in the space.
- the oxygen scavenger is a non-carbon dioxide generating type.
- a packaging material opening portion is provided at a position of a neck portion of the soft bottle in the packaging material.
- a tenth characteristic configuration of the eye perfusion solution container of the present invention is the above-mentioned characteristic configuration, wherein the packaging material opening portion for winding the packaging material around the body of the soft bottle and opening the packaging material in a shape that can be held. It is preferable that a plurality of the packaging materials are provided on the packaging material, and the packaging material opened from the packaging material opening section is arranged so as to be formed on a cover member capable of imparting pressure resistance to the soft bottle.
- the present inventors have conducted intensive studies to solve the convenience of disposing of the eye perfusion solution container, the mixing operability, and the like. As a result, it was found that the oxydartathion-containing solution and the bicarbonate solution can be used independently. It was found that these problems could be solved by housing in a plastic plastic bottle.
- the oxidaltathion-containing solution and the bicarbonate solution are housed in a soft bottle, the convenience in disposal can be increased as in the conventional multi-chamber bag.
- the workability of two-component mixing at the time of use can be enhanced.
- a soft bottle is used, compared to a no-nog, it is possible to apply a more accurate force to the action location when mixing the two solutions at the time of mixing, so that two-component mixing is possible.
- the workability is high, and the mixing worker can perform the two-liquid mixing work without requiring a large work space.
- the soft bottle can be stored independently, and a large amount of an eye perfusion solution container can be stored with a reduced management space. Therefore, in order to keep both components stable, the oxygnoretathione solution and the bicarbonate solution can be stored separately in stable pH ranges, and can be stored and used in a form of mixing both solutions at the time of use.
- a first chamber and a second chamber which are formed in a watertight manner by a partition wall are provided, and an oxydaltathione-containing solution is provided. If the bicarbonate solution and the bicarbonate solution are individually accommodated, there is no danger that they will be mixed in the storage state. Also, both chambers have a partition
- the two chambers are separated from each other, the first chamber and the second chamber are communicated with each other at the time of use by the mixing mechanism, and the two liquids can be easily mixed only by losing the watertightness of the partition walls. it can.
- a non-permeable one is suitable in order to prevent carbon dioxide gas from leaking out of the contained bicarbonate solution part and to prevent inflow of oxygen gas from the outside.
- materials for soft bottles with such physical properties are not well known at present. Therefore, as described in the third feature configuration, if the soft bottle is wrapped by providing a packaging material made of a gas-impermeable plastic, the carbon dioxide gas from inside the bicarbonate solution part is discharged outside the soft bottle. Even when the gas passes through the soft bottle, the gas is stored in the space between the packaging material and the soft bottle, and when the gas concentration in the soft bottle and the gas concentration in the space reach equilibrium, the gas is stored.
- gas permeation can be suppressed, deterioration of the bicarbonate solution can be suppressed.
- the gas that can permeate into the soft bottle from the outside is also limited to the gas in the space, so that the deterioration of the oxyglutathione-containing solution or the bicarbonate solution can be suppressed. it can.
- the packaging material if the packaging material is self-supporting, the packaging material does not hinder the self-supporting of the soft bottle. Can be stored more stably. Therefore, the soft bottle can be stored independently, and a large amount of an eye perfusate container can be stored with a reduced management space.
- the oxygen concentration in the space can be reduced by enclosing an oxygen scavenger in the space.
- the sensitivity of the oxygen detecting agent is improved, and the accuracy of pinhole detection by the oxygen detecting agent can be improved.
- the packaging material when the packaging material is provided with a packaging material opening portion, the packaging material can be easily opened at a predetermined position. If this packing material opening section is provided at the height of the neck of the soft bottle, the soft bottle can be taken out and easily opened, and the oxygen detecting agent and the oxygen scavenger provided inside can be removed. Easy to remove and dispose of.
- the packaging material is provided with a plurality of packaging material opening portions for wrapping the packaging material around the body of the soft bottle and opening the packaging material so that the packaging material can be held. If the packaging material opened from the packaging material opening portion is arranged so as to be formed on a cover member capable of imparting pressure resistance to the soft bottle, even if pressure is applied inside the soft bottle, Said
- the packaging material can prevent the soft bottle from expanding with an increase in internal pressure. Therefore, pressure resistance can be imparted to the soft bottle. Therefore, if a packaging opening portion for further processing the packaging material into a cover member is provided, the packaging material can be easily processed, and the cover member can be effectively used to form a gas in the soft bottle.
- the ocular perfusion solution mixed and prepared inside the soft bottle is applied to a pressurized surgery or the like by press-fitting, it is possible to improve the pressure resistance and use it more safely. Wear.
- the present invention is a container for an eye perfusion solution, and the contained eye perfusion solution comprises an oxydaltathione solution as an active ingredient and a bicarbonate solution as a diluent.
- Oxidaltathione solution and bicarbonate solution are contained in a plastic bottle mixed with plastic for use at the time of use. When used, both solutions are mixed to form an eye perfusion solution.
- the concentration of oxidaltathion in the oxidaltathion solution is preferably 0.1 to 1.0% (W / V).
- an isotonic agent such as sodium chloride, calcium chloride, magnesium chloride, dextrose, etc.
- a pH adjuster such as sodium hydroxide, hydrochloric acid, etc.
- the pH of the oxaldaltathione solution is adjusted in the acidic region, preferably between 3.0 and 6.0.
- the diluent may contain sodium bicarbonate, ammonium bicarbonate, potassium bicarbonate or the like which generates bicarbonate ions, and preferably contains the above-mentioned sodium bicarbonate.
- concentration of sodium bicarbonate in the diluent is preferably 0.1-0.5% (W / V).
- Sodium Shioi ⁇ the diluent, potassium Shioi ⁇ , isotonic agents, such as magnesium chloride, sodium hydrogen phosphate, pH buffering agents such as sodium phosphate, sodium hydroxide, P H tone Seizai such as hydrochloric acid, etc. Can be obtained.
- the pH of the diluent is adjusted to a basic region, preferably 7.0.8.0.
- the mixed-use plastic soft bottle used at the time of use is a container in which the oxidaltathion solution and the bicarbonate solution are separately housed in a single plastic soft bottle, and in a storage state, the room is the same as the room in which the oxyglenolethion solution is housed.
- the mixing mechanism a known method of communicating the two chambers by an operation such as rotation or pushing may be used. Specifically, the sealing portion of the communication hole is peeled off by the rotation operation, and the two chambers communicate (for example, Japanese Patent No. 3231388, Japanese Patent Application Laid-Open No. 2001-161791, Japanese Patent Application Laid-Open No. No. 367663), one in which the closing member of the communication hole is opened and moved with respect to the communication hole by a rotation operation (for example, Japanese Patent Application Laid-Open No. 6-225920, Japanese Patent Publication No.
- the closed state is changed from the closed state to the communicating state by the relative rotation of the two chambers (for example, JP-A-4-329957 and JP-A-5-3905). (For example, Japanese Utility Model Publication No. 51-9510).
- the two liquids can be mixed by a simple operation such as rotating or pushing the cap portion without requiring a large space.
- the plastic soft bottle has appropriate flexibility and is in the shape of a bottle.
- the material may be polyethylene (PE), polypropylene (PP), polyethylene terephthalate (PET), etc., as long as it is a material usually used for medical use, and PP and PE are particularly preferred.
- the capacity of the plastic bottle is preferably 550 mL for the chamber containing the gnoretathione solution and 100-2000 mL for the chamber containing the bicarbonate solution. It is desirable to provide a port on the upper part of the plastic soft bottle. Further, it is preferable to install a foldable hanging tool on the outer surface of the bottom so that it can be hung on a hook during perfusion.
- Gas-impermeable plastic packaging materials include PET films, nylon films, linear low-density polyethylene (LLDPE) films, polyvinyl alcohol films, saponified ethylene-vinyl alcohol copolymer films, polyvinylidene chloride films, and the like.
- Aluminum oxide (alumina) or the like is deposited on the surface, or a laminate of these films.
- the material of the packaging material is preferably a film laminated from the outermost layer in the order of alumina-deposited PET nylon LLDPE.
- the gas-impermeable plastic packaging material is processed by, for example, laminating two films and sealing the outer periphery, or processing the film by folding the! Film and sealing the remaining three sides. What is necessary is just to be able to accommodate a plastic soft bottle. Furthermore, it is desirable to have a bottomed and self-supporting shape. As such a shape, a bag in which a wrapping material is folded inward in a fold shape and a gusset is provided at the bottom is generally used (for example, FIG. 6 of Japanese Patent Publication No. 5-88673). In this way, the self-standing shape allows the plastic soft bottle to be stored upright even if it is wrapped in a packaging material.
- the use of a self-supporting packaging material has the following advantages.
- the wrapping material is merely a bag
- the container is three-dimensional, whereas the wrapping material is planar, so that the packaging material is likely to wrinkle near the container bottom.
- the packaging material is made to be a free-standing type, it can be fitted into the shape of the container and can prevent pinholes of the packaging material from being easily wrinkled. If a pinhole occurs in the packaging material, carbon dioxide gas accumulated in the space is released to the outside, and the release of carbon dioxide gas from the bicarbonate solution is promoted. This raises the pH of the bicarbonate solution, but the solution whose pH has risen is degraded and can no longer be used as a perfusate. Since pinholes are less likely to enter the packaging material, the storage condition of the perfusate is improved and the quality of the perfusate is easily maintained at a high level.
- the power of gradually releasing carbon dioxide from the bicarbonate solution In order to minimize the release of carbon dioxide, the volume of the space between the plastic soft bottle and the packaging material should be as small as possible. It is desirable to make it smaller.
- the packaging material When packaging a bottle-shaped container with packaging material, it is better for the packaging material to have a free-standing shape with a gusset at the bottom than for a simple bag shape, because the packaging material fits more closely into the container shape, The volume of the part can be reduced.
- it is preferable to set the length of the inner circumference of the packaging material so that there is as little gap as possible between the packaging material and the body of the plastic soft bottle.
- a notch (packing material opening portion) as a packaging material opening portion can be provided in the packaging material so as to be cut at the height of the neck of the plastic soft bottle.
- the soft bottle can be easily taken out of the packaging material, and the opened packaging material can be given pressure resistance to the soft bottle in a state of being wound and held around the body of the soft bottle. Formed on the cover member.
- the packaging material at the portion below the neck after cutting the packaging material opening portion can be used as a cover for the plastic soft bottle, and the expansion of the soft bottle can be suppressed, so that it can be used for pressurized surgery. If there is a gap between the wrapping material and the body of the plastic soft bottle, it is desirable to fix the wrapping material with a rubber band or cloth belt from above so that the wrapping material does not slip down.
- the eye perfusion solution container of the present invention can be similarly applied to pressurized surgery by removing the packaging material and covering the outside of the plastic soft bottle with a hard mold or the like. [0041]
- the space between the packaging material and the plastic soft bottle does not need to be filled with gas, and may be left as air. Alternatively, nitrogen gas may be filled.
- an oxygen detector in the space between the packaging material and the plastic soft bottle. This makes it possible to detect the oxygen flowing into the space from the pinhole and confirm the presence of the pinhole.
- the oxygen detector is not particularly limited as long as its physical properties are changed by the presence of oxygen, but those whose color changes by the presence of oxygen are preferable.
- Examples of the form of the oxygen detector include a tablet type and a paper type, but there is no particular limitation.
- a specific example of the oxygen detecting agent is Ageless Eye c (Mitsubishi Gas Chemical Co., Ltd.).
- an oxygen absorber in the space. If the oxygen concentration in the space is reduced with a deoxidizer, the sensitivity of the oxygen detector will be improved.
- a catechol-based oxygen scavenger that generates and absorbs a small amount of carbon dioxide is preferable.
- a specific example of such an oxygen scavenger is Tamitsu D (Oji Tack Co., Ltd.).
- the eye perfusion solution container of the present invention separates the above-mentioned oxydaltathione-containing solution and the bicarbonate solution into separate containers when not in use.
- the medicine bottles are stored in a soft bottle X, and when used, a plurality of medicines can be mixed by aseptically communicating a housing part containing these medicines, so that the medicines can be used.
- the soft bottle X includes a first storage member 10 that stores a solution containing oxygnoretathione, a bicarbonate solution, and the first storage member 10.
- a second housing member 20 that communicates through the communication passage 61.
- the first storage member 10 forms a first chamber 11 for storing an oxyglutathione-containing solution
- the second storage member 20 forms a second chamber 21 for storing a bicarbonate solution.
- the communication path 61 is formed by a cutout portion provided in the partition wall 60, and forms a mixing mechanism that opens and closes the communication path 61 with a protruding piece 70 so that it can be sealed or opened.
- the first housing member 10 is sealed by a lid member 30, and a cap member 40 rotatable about the lid member 30 about an axis is engaged and mounted on the first storage member 10.
- the protruding piece 70 is engaged and fixed to the cap member 40 or the lid member 30, and when the lid member 30 and the cap member 40 are fitted to the first housing member 10,
- the oxidaltathion-containing solution and the bicarbonate solution are separated by the partition wall 60 and can be stored separately (see FIG. 4 (a)).
- the communication path 61 is configured to be in communication with the oxydaltathione-containing solution and the bicarbonate solution so that the mixture can be switched to a mixable state (see FIG. 4B).
- Each of the first storage member 10 and the second storage member 20 can be formed to have a capacity corresponding to the amount of medicine to be stored.
- the first chamber 11 of the first storage member 10 has a capacity of 20 mL
- the second chamber 21 of the second storage member 20 has a capacity of 480 mL.
- the first accommodating member 10 and the second accommodating member 20 may be integrally formed, or may be formed as separate members and then connected so as to communicate with each other via the partition wall 60. .
- the first housing member 10 and the second housing member 20 can be formed into an arbitrary shape, but the first housing member 10 rotates the lid member 30 and the cap member 40. If necessary, it is preferable to form it into a cylindrical shape.
- the second storage member 20 can adopt a shape suitable for being carried at the time of use, for example, a cylindrical shape or a tube shape.
- the lid member 30 is made of an elastic material such as a rubber material, and the entire formed lid member 30 is configured to be elastically deformable to some extent.
- the lid member 30 is provided with a needle sticking portion 31. Since the lid member 30 and the inner surface of the first housing member 10 can be in close contact with each other by being formed so as to be elastically deformable in this manner, the oxidaltathion-containing solution housed in the first housing member 10 contains the solution. However, leakage from the first storage member 10 can be prevented, and the mixed and formed eye perfusion solution is applied to the needle member pierced by the needle piercing portion 31. This is a configuration that can be derived outside of Soft Bottle X.
- a hanging member made of a ring-shaped member for hanging the soft bottle in an inverted posture is continuously provided.
- the soft bottle X contains the oxydartathione-containing solution and the bicarbonate solution separately and stores them in the packaging material 80 in a storable state. Is done.
- the packaging material 80 is formed by bending a resin film to form a gusset at the bottom, and is sealed on both sides as a self-supporting shape.
- a carbon dioxide-free oxygen absorber 90 With the oxygen detecting agent 91 accommodated therein, the upper portion is sealed and the space between the soft bottle X and the packaging material 80 is filled with air or nitrogen gas to form a sealed state.
- the packaging material 80 is provided with a notch (packing material opening portion) 81 so that the packaging material can be easily opened when the soft bottle is taken out.
- the notch 81 is provided as a pair at the height of the neck of the soft bottle X, and another pair of notches 81 is provided below the notch 81 by the length of the body of the soft bottle X.
- a cover member 100 is formed by cutting the packaging material 80 into a ring shape.
- the cover member 90 is used as a cover that suppresses the inside of the soft bottle X from being pressurized and expanding the soft bottle X when performing a pressure-type operation in a state where the soft bottle X is attached to the soft bottle X. Can be used (see Figure 5).
- a soft bottle made of PP is filled with 480 mL of bicarbonate solution, and a PP power capsule with a communication system is welded. Stoppered. From the outermost layer, the above soft bottle was placed in a free-standing bottomed packaging material consisting of films laminated in the order of alumina-deposited PET-Nylon-LLDPE, and an oxygen detector (Ageless Eye C Mitsubishi Gas Chemical Co., Ltd.) and an oxygen absorber ( (Tamotsu D Oji Tack Co., Ltd.), and the upper part of the packaging material was sealed with a heat seal to obtain a Mego perfusate container.
- the oxygnoretathione solution and the bicarbonate solution were each prepared. It can be stored and used in the form of a mixture of both solutions when stored separately in a stable pH range, and the convenience of disposal can be increased.For example, cataract surgery, vitreous surgery, glaucoma surgery, etc. Ophthalmic hands
- the present invention can be applied to a container for an ocular perfusion solution containing oxidaltathion as an active ingredient.
- FIG. 1 is a view showing an embodiment of an eye perfusion solution container of the present invention.
- FIG. 2 is an exploded perspective view of the eye perfusion solution container of FIG. 1.
- FIG. 3 is an explanatory view of a main part of a soft bottle.
- FIG. 4 is an explanatory view of a mixing mechanism.
- FIG. 5 is an explanatory view in which a packaging material is used as a cover during pressurized surgery.
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Package Specialized In Special Use (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003187868 | 2003-06-30 | ||
JP2003-187868 | 2003-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005000190A1 true WO2005000190A1 (ja) | 2005-01-06 |
Family
ID=33549736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/009140 WO2005000190A1 (ja) | 2003-06-30 | 2004-06-29 | 眼灌流液収容体 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005000190A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007016005A (ja) * | 2005-07-11 | 2007-01-25 | Santen Pharmaceut Co Ltd | オキシグルタチオン含有水溶液 |
EP3949950A4 (en) * | 2019-04-04 | 2023-01-18 | Fuso Pharmaceutical Industries, Ltd. | RESERVOIR FOR CARDIOPLEGIC SOLUTION WITH BICARBONATIONS AND METHOD OF PRODUCTION THEREOF |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60142713U (ja) * | 1984-02-29 | 1985-09-21 | 大日本印刷株式会社 | 耐圧容器 |
JP2000288066A (ja) * | 1999-04-07 | 2000-10-17 | Otsuka Pharmaceut Factory Inc | 眼灌流・洗浄液バッグ包装体 |
JP2001192069A (ja) * | 1999-10-25 | 2001-07-17 | Nipro Corp | 重炭酸塩含有薬液充填容器包装体 |
JP3202541B2 (ja) * | 1995-06-14 | 2001-08-27 | 株式会社細川洋行 | 輸液バッグ用外装袋 |
JP2001252334A (ja) * | 2000-03-08 | 2001-09-18 | Otsuka Pharmaceut Factory Inc | 輸液バッグ用の外装袋および外装カバーと、それらを用いた輸液バッグの保存方法および使用方法 |
JP3240253B2 (ja) * | 1995-10-27 | 2001-12-17 | 住友ベークライト株式会社 | 点滴用包装容器の汚染防止袋 |
JP3312842B2 (ja) * | 1996-03-28 | 2002-08-12 | 株式会社細川洋行 | 酸素遮断性透明包装材料及び袋体 |
-
2004
- 2004-06-29 WO PCT/JP2004/009140 patent/WO2005000190A1/ja not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60142713U (ja) * | 1984-02-29 | 1985-09-21 | 大日本印刷株式会社 | 耐圧容器 |
JP3202541B2 (ja) * | 1995-06-14 | 2001-08-27 | 株式会社細川洋行 | 輸液バッグ用外装袋 |
JP3240253B2 (ja) * | 1995-10-27 | 2001-12-17 | 住友ベークライト株式会社 | 点滴用包装容器の汚染防止袋 |
JP3312842B2 (ja) * | 1996-03-28 | 2002-08-12 | 株式会社細川洋行 | 酸素遮断性透明包装材料及び袋体 |
JP2000288066A (ja) * | 1999-04-07 | 2000-10-17 | Otsuka Pharmaceut Factory Inc | 眼灌流・洗浄液バッグ包装体 |
JP2001192069A (ja) * | 1999-10-25 | 2001-07-17 | Nipro Corp | 重炭酸塩含有薬液充填容器包装体 |
JP2001252334A (ja) * | 2000-03-08 | 2001-09-18 | Otsuka Pharmaceut Factory Inc | 輸液バッグ用の外装袋および外装カバーと、それらを用いた輸液バッグの保存方法および使用方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007016005A (ja) * | 2005-07-11 | 2007-01-25 | Santen Pharmaceut Co Ltd | オキシグルタチオン含有水溶液 |
EP3949950A4 (en) * | 2019-04-04 | 2023-01-18 | Fuso Pharmaceutical Industries, Ltd. | RESERVOIR FOR CARDIOPLEGIC SOLUTION WITH BICARBONATIONS AND METHOD OF PRODUCTION THEREOF |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI107695B (fi) | Säiliö, jossa on useita kammioita | |
US4150744A (en) | Packaging | |
JP3079403B2 (ja) | 複室容器 | |
KR100209830B1 (ko) | 다수의 챔버를 갖는 저장용기 | |
WO2005107680B1 (en) | Collapsible fluid containers | |
JP3060133U (ja) | 眼灌流・洗浄液バッグ包装体 | |
JP2005343492A (ja) | 自立袋 | |
JP3060132B2 (ja) | 複室容器 | |
JP2007161254A (ja) | スパウト付き容器 | |
JP2005349182A (ja) | 薬剤容器 | |
JP3060133B2 (ja) | 複室容器 | |
WO2005000190A1 (ja) | 眼灌流液収容体 | |
JP2005034639A (ja) | 眼灌流液収容体 | |
JPH105313A (ja) | 医療用容器の包装方法 | |
JP2000084042A (ja) | 輸液容器の保管・保存方法 | |
JP2000175989A (ja) | 薬液容器 | |
JP2003267454A (ja) | 包装体 | |
JP6210273B2 (ja) | 医療用複室容器の梱包体及び同容器の梱包方法 | |
JP3070596U (ja) | 複室容器 | |
JP2005007053A (ja) | 輸液バッグ保存用外装袋 | |
JPH1176367A (ja) | 医療用容器 | |
JPH10236541A (ja) | 複室容器 | |
JP2001252333A (ja) | 医療用複室容器 | |
JPH10324374A (ja) | 混合容器 | |
JP4178373B2 (ja) | 袋体およびその開口・充填方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |